13668-453 : Anagrelide .5 mg Oral Capsule
| NDC: | 13668-453 |
| Labeler: | Torrent Pharmaceuticals Limited |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Anagrelide |
| Dosage Form: | Oral Capsule |
| Application #: | ANDA209151 |
| Rev. Date: |
Appearance:
| Markings: | 1453;05 |
| Shapes: |
Capsule |
| Colors: |
 Gray |
| Size (mm): | 4 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 13668-453-01: 100 CAPSULE IN 1 BOTTLE (13668‑453‑01)
- 13668-453-30: 30 CAPSULE IN 1 BOTTLE (13668‑453‑30)
- 13668-453-74: 100 CAPSULE IN 1 CARTON (13668‑453‑74)
Active Ingredients:
- Anagrelide Hydrochloride
Dosage Strength:
- .5 mg
Inactive Ingredients:
- Cellulose, Microcrystalline
- Croscarmellose Sodium
- Ferrosoferric Oxide
- Gelatin
- Hydroxypropyl Cellulose (Type H)
- Lactose Monohydrate
- Magnesium Stearate
- Potassium Hydroxide
- Propylene Glycol
- Shellac
- Titanium Dioxide
Pharmaceutical Classes:
- Decreased Platelet Production [PE]
- Phosphodiesterase 3 Inhibitors [MoA]
- Platelet-reducing Agent [EPC]
Related Products:
Based on records with the same trade name.- 13668-462 Anagrelide 1 mg Oral Capsule by Torrent Pharmaceuticals Limited
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 13668-443Next: 13668-462 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.